Montag & Caldwell’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,397,498
Closed -$297M 120
2014
Q4
$297M Sell
1,397,498
-182,757
-12% -$36.3M 3.25% 12
2014
Q3
$282M Sell
1,580,255
-799,564
-34% -$133M 2.93% 18
2014
Q2
$403M Sell
2,379,819
-1,372,243
-37% -$214M 3.61% 9
2014
Q1
$466M Sell
3,752,062
-570,919
-13% -$69.5M 4.07% 2
2013
Q4
$480M Sell
4,322,981
-459,130
-10% -$43.9M 3.59% 4
2013
Q3
$433M Sell
4,782,111
-276,441
-5% -$24.8M 3.26% 8
2013
Q2
$426M Buy
+5,058,552
New +$525M 3.2% 12

Other funds holding AGN

Montag & Caldwell's AGN Position: Q1 2015 in Review

Montag & Caldwell sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,397,498 shares — an estimated $297M sold.

Montag & Caldwell first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $480M in Q4 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Montag & Caldwell reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Montag & Caldwell sold 1,397,498 Allergan Inc shares in Q1 2015, an estimated $297M.
  • Montag & Caldwell first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Montag & Caldwell's Allergan Inc position peaked at $480M in Q4 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Montag & Caldwell's 13F filing for Q1 2015, filed 1 May 2015.